Results

Total Results: 330 records

Showing results for "sedation".

21. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients With Epilepsy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
    February 01, 2008 - Potentiate GABA receptor function Absence Atypical Absence Myoclonic Neurological: ataxia, sedation … and increase GABA availability Partial Lennox- Gastaut Neurological: insomnia, dizziness, sedation … Tonic- Clonic Atypical Absence Myoclonic Lennox- Gastaut Neurological: dizziness, diplopia, sedation … Yes Phenobarbital Potentiate GABA receptor function Partial Tonic- Clonic Neurological: sedation … No Tiagabine Increase GABA availability Partial Tonic- Clonic Neurological: confusion, sedation

22. Plant-Based-Chronic-Pain-Review-Q3-Tables-F5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-chronic-pain-review-q3-tables-f5.xlsx
    June 15, 2021 - none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs. 23% (12/52) vs. 9% (5/55) Sedation … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

23. TND-0775-150722 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0775-150722.pdf
    May 12, 2015 - medications, such as Parkinsonism, akathisia, dystonia, and tardive dyskinesia), prolactin elevation, sedation … medication (e.g., diabetes mellitus, extrapyramidal symptoms / tardive dyskinesia, prolactin elevation, sedation

24. Evidence Summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
    January 01, 2022 - There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … high-THC to CBD) may be associated with moderate improvement in pain severity, but with increased risk of sedation … Studies) [SOE] Dizziness Effect Size (N Studies) [SOE] Nausea Effect Size (N Studies) [SOE] Sedation … the results with recent systematic reviews that used the same methodology, suggests that the risk of sedation … placebo, these interventions resulted in greater risk of common adverse events (dizziness, nausea, sedation

25. Evaluation and Treatment of Tinnitus: Comparative Effectiveness | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/tinnitus/research
    August 23, 2013 - The SOE for the adverse effect of sedation in pharmacological studies was judged insufficient.

26. Benefits and Harms of Routine Preoperative Testing: Comparative Effectiveness | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/preoperative-testing/research
    January 29, 2014 - of both adults and children undergoing surgical and other procedures requiring either anesthesia or sedation

27. Cannabis-App-F5-Table-Surveillance-Report-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2.xlsx
    January 22, 2022 - none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs. 23% (12/52) vs. 9% (5/55) Sedation … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

28. Appendix-E-Table-E5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5.xlsx
    November 04, 2021 - none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs. 23% (12/52) vs. 9% (5/55) Sedation … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

29. Cannabis-App-F5-Table-Surveillance-Report-2 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0.xlsx
    February 16, 2022 - none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs. 23% (12/52) vs. 9% (5/55) Sedation … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

30. Evidence Summary: Comparative Effectiveness Review No. 236 Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-236-mental-health-pregnancy-evidence-summary.pdf
    April 01, 2021 - • Brexanolone probably improves depressive symptoms; it may increase the risk of sedation or somnolence … in the third trimester or within 4 weeks of birth, brexanolone may be associated with the risk of sedation

31. Cannabis-App-F5-Table-Surveillance-Report-2 0 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
    February 16, 2022 - none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs. 23% (12/52) vs. 9% (5/55) Sedation … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

32. Appendix-E-Table-E5 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
    November 04, 2021 - none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs. 23% (12/52) vs. 9% (5/55) Sedation … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

33. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
    April 01, 2022 - Consistent with prior evidence, gabapentin was associated with increased risk of dizziness, sedation … in cognitive AEs • SOE: Low. based on 8 RCTs Large increase in dizziness, peripheral edema, sedation … (n=366) found increased risk of dizziness.6,7,9 1 RCT (n=306) found increased risk of SAEs, sedation … THC/CBD associated with large increase in WAEs, dizziness, nausea, but no increase in SAEs or sedation … SOE for large increase in risk for cognitive effects, moderate SOE for large increase in risk for sedation

34. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
    April 01, 2022 - Consistent with prior evidence, gabapentin was associated with increased risk of dizziness, sedation … in cognitive AEs • SOE: Low. based on 8 RCTs Large increase in dizziness, peripheral edema, sedation … (n=366) found increased risk of dizziness.6,7,9 1 RCT (n=306) found increased risk of SAEs, sedation … THC/CBD associated with large increase in WAEs, dizziness, nausea, but no increase in SAEs or sedation … SOE for large increase in risk for cognitive effects, moderate SOE for large increase in risk for sedation

35. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
    February 01, 2012 - Other common side effects are dry mouth and sedation. … Patient-, parent- or care impressions symptoms side effects provider-reported outcomes Depression Tics Sedation … difference. sexual AE (1 RCT, 1 PCS) Haloperidol vs. risperidone Low No significant difference. (2 RCTs) Sedation … SGA (continued) Sedation Clozapine vs. olanzapine Low No significant difference. (1 RCT, 1 PCS, 1 RCS … Sedation Aripiprazole vs. placebo (4 RCTs) Low Significant effect in favor of placebo (RR = 2.7, 95%

36. Pbt-Lsr-Draft-Ets-Obs (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-draft-ets-obs.xlsx
    March 15, 2022 - none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs. 23% (12/52) vs. 9% (5/55) Sedation … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

37. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
    July 01, 2022 - from Surveillance Report 2 found increased risk of WAEs and nonsignificantly increased risk of sedation … 95% CI, 1.88 to 5.34, I2=0%) • Dizziness (28 RCTs): RR 2.85 (95% CI, 2.43 to 3.34, I2=36%) • Sedation … THC/CBD associated with large increase in WAEs, dizziness, nausea, but no increase in SAEs or sedation … 4.48 (95% CI, 2.77 to 7.22, I2=0%) • Nausea (2 RCTs): RR 2.11 (95% CI, 1.20 to 3.72, I2=0%) • Sedation … Gabapentin/pregabalin harms, sedation Abbreviations: CI=confidence interval; CPP=chronic pelvic pain

38. Antipsychotics-Children-Surveillance-150120 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
    October 01, 2014 - One review (Ching & Pringsheim, 2012) found increased weight gain and higher risk ratios for sedation … Notable side effects must be considered, however, such as weight gain, sedation, drooling, and tremor … The most common AEs were sedation (26.5%), somnolence (23.5%), headache (22.2%), and insomnia (13.6% … Eight patients (20.0%) experienced moderate to severe sedation and eight (20.0%) experienced increased … For nearly all outcomes ratios for sedation and increased risk for weight regard to new evidence and

39. Routine Preoperative Testing: Comparative Effectiveness Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/preoperative-testing/research-protocol
    May 14, 2013 - any elective or ambulatory surgical or other invasive procedure that commonly requires anesthesia or sedation … team member; cataract surgery will be included regardless of local practice regarding anesthesia or sedation … surgeries) Exclude patients undergoing nonsurgical diagnostic procedures that may require anesthesia or sedation … after routine preoperative testing in patients undergoing surgery or procedures requiring anesthesia or sedation … plan to explore differences across: Types of and indications for surgery Types of anesthesia or sedation

40. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
    July 01, 2022 - from Surveillance Report 2 found increased risk of WAEs and nonsignificantly increased risk of sedation … 95% CI, 1.88 to 5.34, I2=0%) • Dizziness (28 RCTs): RR 2.85 (95% CI, 2.43 to 3.34, I2=36%) • Sedation … THC/CBD associated with large increase in WAEs, dizziness, nausea, but no increase in SAEs or sedation … 4.48 (95% CI, 2.77 to 7.22, I2=0%) • Nausea (2 RCTs): RR 2.11 (95% CI, 1.20 to 3.72, I2=0%) • Sedation … Gabapentin/pregabalin harms, sedation Abbreviations: CI=confidence interval; CPP=chronic pelvic pain